NCT05471427View on ClinicalTrials.gov

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer

CompletedOBSERVATIONAL

Enrollment

118

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions

Elderly PatientsMetastatic Prostate Cancer

Interventions

DRUG

Taxane chemotherapy

Patients underwent taxane chemotherapy according to clinical practice for metastatic prostate cancer

Trial Locations (1)

50134

AOU Careggi Radiation Oncology Unit, Florence

All Listed Sponsors

lead

Azienda Ospedaliero-Universitaria Careggi

OTHER

NCT05471427 - Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer | Biotech Hunter | Biotech Hunter